Arief S. Gunawan, Donal P. McLornan, Bridget Wilkins, Katherine Waghorn, Yvette Hoade, Nicholas C. P. Cross, and Claire N. Harrison. 2017. “Ruxolitinib, a Potent JAK1/JAK2 Inhibitor, Induces Temporary Reductions in the Allelic Burden of Concurrent CSF3R Mutations in Chronic Neutrophilic Leukemia”. Haematologica 102 (6). Pavia, Italy, e238-e240. https://doi.org/10.3324/haematol.2017.163790.